Combinatory Rehabilitation Used for Substantially Helping Individuals With Traumatic Brain Injury
NCT ID: NCT05716048
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
60 participants
INTERVENTIONAL
2023-04-21
2028-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
If successful, this trial will provide Class I evidence of combined KF-mSMT and AET for rehabilitating NLMI in TBI, based on standards published for therapeutic trials by the American Academy of Neurology, thus positioning such an approach within the clinician's arsenal for robustly managing NLMI. By augmenting the effects of KF-mSMT with AET, we anticipate this treatment will ultimately help those with TBI-related NLMI return to the workforce, independently manage their everyday lives, and maintain optimal quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
NCT06197685
Improving New Learning and Memory in Traumatic Brain Injury
NCT01207375
Aerobic Exercise to Improve Memory in TBI
NCT01952704
Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI
NCT03478059
Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: Project EXACT
NCT03677440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KF-mSMT Plus Aerobic Exercise Training
Participants will undergo 12 weeks of supervised aerobic cycling exercise training. During the last 8 weeks of cycling exercise, participants will also undergo treatment with the Kessler Foundation modified Story Memory Technique as an approach for cognitive rehabilitation.
KF-mSMT Plus Aerobic Exercise Training
Participants will undergo this combinatory intervention 3 days per week for 12 weeks. The combined session duration will begin with 15 minutes and last up to 2 hours by the end of the 12th week
KF-mSMT Plus Stretching Exercise Training
Participants will undergo 12 weeks of supervised stretching and toning exercise training. During the last 8 weeks of stretching exercise, participants will also undergo treatment with the Kessler Foundation modified Story Memory Technique as an approach for cognitive rehabilitation.
KF-mSMT Plus Stretching Exercise Training
Participants will undergo this combinatory intervention 3 days per week for 12 weeks. The combined session duration will begin with 15 minutes and last up to 2 hours by the end of the 12th week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KF-mSMT Plus Aerobic Exercise Training
Participants will undergo this combinatory intervention 3 days per week for 12 weeks. The combined session duration will begin with 15 minutes and last up to 2 hours by the end of the 12th week
KF-mSMT Plus Stretching Exercise Training
Participants will undergo this combinatory intervention 3 days per week for 12 weeks. The combined session duration will begin with 15 minutes and last up to 2 hours by the end of the 12th week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of moderate-to-severe TBI based on TBIMS criteria at least one year prior to enrollment
* Having no to low substance use / involvement (drug/alcohol) as documented via ASSIST
* Being insufficiently physically active based on a Godin Leisure-Time Exercise Questionnaire Health Contribution Score of \<14
* Having a proficiency in the English language
* Being right handed to control for brain organization
* Having chronic medical conditions (e.g. diabetes) in addition to TBI will require approval to participate from a physician, consistent with PAR-Q+.
* Having an in-tact ability to follow directions based on the Telephone Interview for Cognitive Status (TICS-M) (i.e., TICS-M scores of ≥18)
* Demonstrating new learning and memory impairment based on Open-Trial Selective Reminding Task (OT-SRT) scores at least 1.5 standard deviations below healthy controls (8+ trials to reach criterion)
Exclusion Criteria
* Having a history of neurological disorders beyond TBI
* Having a history of severe mental illness (e.g., schizophrenia, bipolar, severe major depression)
* Having metal in the body, claustrophobia, and other risk factors that would make MRI scanning unsafe.
* Having moderate or high risk for exercise training contraindications (e.g. diabetes), defined as ≥1 YES on pages 2-3 of the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+)
* Having significantly impaired vision by scotomas (corrected vision in worse eye worse than 20/60), diplopia, or nystagmus.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Sandroff
Senior Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy D Chiaravalloti, PhD
Role: PRINCIPAL_INVESTIGATOR
Kessler Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
West Orange, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Brian M Sandroff, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-1195-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.